| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 43 |
| 1 | VANCOMYCIN | 42 |
| 2 | ADALIMUMAB | 39 |
| 3 | ASPIRIN | 38 |
| 4 | BEVACIZUMAB | 38 |
| 5 | ASPIRIN 325 MG | 36 |
| 6 | ASPIRIN 81 MG | 36 |
| 7 | SILDENAFIL CITRATE | 23 |
| 8 | LIDOCAINE HYDROCHLORIDE | 22 |
| 9 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVANAFIL | 3 | 0.0429 |
| 1 | BEVACIZUMAB-MALY | 2 | 0.0100 |
| 2 | SODIUM HYALURONATE | 5 | 0.0061 |
| 3 | VARDENAFIL | 3 | 0.0050 |
| 4 | VADADUSTAT | 1 | 0.0033 |
| 5 | FLUORESCEIN | 2 | 0.0032 |
| 6 | MEPIVACAINE HYDROCHLORIDE | 3 | 0.0026 |
| 7 | VERTEPORFIN FOR INJECTION | 3 | 0.0020 |
| 8 | CERLIPONASE ALFA | 1 | 0.0019 |
| 9 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 2 | 0.0031 |
| 1 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 3 | Photoenhancer [EPC] | 3 | 0.0008 |
| 4 | Glycopeptide Antibacterial [EPC] | 43 | 0.0007 |
| 5 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 10 | 0.0005 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 86 | 0.0005 |
| 8 | Quinolone Antimicrobial [EPC] | 4 | 0.0004 |
| 9 | Ester Local Anesthetic [EPC] | 20 | 0.0004 |